Founded in 1997, Ergomed is a full-service Phase I-IV clinical development & trial management service partner with leading expertise in developing oncology & rare disease drugs. Our portfolio includes working with novel therapies, early phase development, immunotherapy & adaptive trial designs. Ergomed embodies a patient-centric approach with access to global patients in vital geographical areas. Our proven delivery record, expertise & true partnership means our sponsors can trust us to deliver their oncology trials whatever the challenge. Including industry-leading PV solutions PrimeVigilance